As negative control, we employed an AS1411-control AsiC (AS1411 aptamer conjugated with control siRNA) (Figure 2B) and Scramble-SMG1 AsiC to assess that the targeting to the cancer cells was AS1411 dependent (Figure S1D). The gene discussed is SMG1; the disease is cancer.